DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells
Biomedical Reports · 24.02.2023 · 18 (4)
DOI: 10.3892/br.2023.1610 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Reports, online erschienen am 24.02.2023. Verfasst von Kentaro Ohuchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reconstructive Surgery for Oral and Maxillofacial Region, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sc…. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Reconstructive Surgery for Oral and Maxillofacial Region, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sciences University of Hokkaido, Tobetsu-cho, Ishikari-gun, Hokkaido 061…
- Department of Radiation Science, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036-8564, Japan.
- Pathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Chuo-ku, Tokyo 103-0027, Japan.
Zitieren
APA
Ohuchi, K., Saga, R., Hasegawa, K., Tsuruga, E., Hosokawa, Y., Fukumoto, M., & Okumura, K. (2023). DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells. Biomedical Reports, 18(4). https://doi.org/10.3892/br.2023.1610
Vancouver
Ohuchi K, Saga R, Hasegawa K, Tsuruga E, Hosokawa Y, Fukumoto M, et al. DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells. Biomedical Reports. 2023;18(4). doi:10.3892/br.2023.1610
BibTeX
@article{Ohuchi2023,
author = {Ohuchi, Kentaro and Saga, Ryo and Hasegawa, Kazuki and Tsuruga, Eichi and Hosokawa, Yoichiro and Fukumoto, Manabu and Okumura, Kazuhiko},
title = {DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells},
journal = {Biomedical Reports},
year = {2023},
volume = {18},
number = {4},
doi = {10.3892/br.2023.1610}
}
EUVIMED